A detailed history of Pacific Point Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Pacific Point Advisors, LLC holds 15,335 shares of NVO stock, worth $1.28 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
15,335
Holding current value
$1.28 Million
% of portfolio
0.77%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

BUY
$85.0 - $120.04 $1.3 Million - $1.84 Million
15,335 New
15,335 $1.27 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $189B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pacific Point Advisors, LLC Portfolio

Follow Pacific Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Point Advisors, LLC with notifications on news.